Get complete Patent Opposition Report for Cms Cameron Mckenna Nabarro Olswang

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Cms Cameron Mckenna Nabarro Olswang against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024
EP3542790Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024
EP3636778Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)FRED HUTCHINSON CANCER CENTEROct 12, 2022
EP2863895Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 14, 2022
EP2350096Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALSAug 6, 2020
EP3149481Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1VENTANA MEDICAL SYSTEMSOct 9, 2019
EP2827845Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKSep 26, 2019
EP3111221Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3VENTANA MEDICAL SYSTEMSJul 10, 2019
EP3009143Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S DiseaseNEURODYN LIFE SCIENCESJul 3, 2019
EP3080279Methods And Compositions For The Targeted Modification Of A GenomeREGENERON PHARMACEUTICALSOct 1, 2018